SCARLET POPPY SCOPOLIA

SCARLET POPPY (Papaver bracteatum Lindl.) +

Activities (Scarlet Poppy) :
Analgesic (1; CRC); Antinarcotic (1; CRC); Antitussive (f; CRC); Aphrodisiac (1; CRC); Sedative (f; CRC); Tranquilizer (f; CRC).

Indications (Scarlet Poppy) :
Addiction (1; CRC); Insomnia (f; CRC); Nervousness (f; CRC); Pain (1; CRC); Schizophrenia (1; CRC); Withdrawal (1; CRC).


SCOPOLIA (Scopolia carniolica Jacq.) XXX

Activities (Scopolia) :
Anticholinergic (2; KOM; PHR; PH2); Antispasmodic (1; KOM; PH2); Bitter (f; PH2); Cerebrosedative (f; EFS); Diuretic (f; EFS); Intoxicant (f; CRC); Mydriatic (1; EFS; FNF); Myorelaxant (2; KOM; PH2); Narcotic (f; CRC; PH2); Parasympatholytic (2; KOM; PHR; PH2); Positive Chronotropic (2; KOM); Positive Dromotropic (2; KOM); Sedative (1; CRC; EFS); Toxic (f; EFS).

Indications (Scopolia) :
Addiction (f; CRC); Cholecystosis (2; PHR; PH2); Colic (f; CRC; PH2); Cramp (1; KOM; PH2); Cramp, bile duct (2; KOM; PH2); Cramp, GI (2; KOM; PH2); Cramp, urinary tract (2; KOM; PH2); Enterosis (1; PHR; PH2); Epilepsy (f; CRC); Gastrosis (1; PHR; PH2); Gout (f; CRC); Hepatosis (2; PHR; PH2); Hysteria (f; CRC); Insomnia (1; CRC; EFS); Myosis (1; PHR); Nervousness (1; CRC; EFS); Nymphomania (f; CRC); Pain (1; PH2); Paralysis (f; CRC); Rheumatism (f; CRC); Tremor (1; PHR; PH2); Urethrosis (2; KOM); Water Retention (f; EFS).

Dosages (Scopolia) :
6–120 mg root (HHB); equivalent to 0.25 (average) 3 (maximum) mg total alkaloids, calculated as hyoscyamine/day (KOM).

Contraindications, Interactions, and Side Effects (Scopolia) :
Class 3 (AHP). “Health hazards not known with proper therapeutic dosages” (PH2). Commission E reports contraindications, adverse effects, and interactions of belladonna alkaloids (AEH). Contraindications: megacolon, narrow-angle glaucoma, prostate adenoma with residual urine, stenosis of the GI tract, and tachycardia (KOM); interactions: may increase activity of amantadine, quinidine, and tricyclic antidepressants (KOM); side effects: arrhythmia, difficult urination, disturbance of ocular accommodation, dry mouth, hyperthermia, mydriasis, obstipation, reduced perspiration, and tachycardia (KOM; PHR; PH2). High doses can cause compulsive speech, delirium, excitation, hallucinations, manic episodes, followed by exhaustion and sleep. “Lethal dosages include the danger of asphyxiation (for adults starting at 100 mg atropine, depending upon alkaloid content, between 20 to 50 gm of the drug, considerably less for children)” (PHR).